Azafaros
PrivateLast Round
Series B
May 13, 2025
Total Funding Raised
$174.14M
Company Overview
Azafaros is a biopharmaceutical company developing disease-modifying therapeutics for rare lysosomal storage disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Azafaros Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Azafaros Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2025 | ||||
| Series A | Feb 6, 2020 | ||||
| Seed | Jul 23, 2018 |
Key People
Founding team and executive leadership
Azafaros Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pictet Group | Series B |
| Asahi Kasei Pharma Venture Capital | Series B |
| BioMedPartners | Series B, Series A |
| Asahi Kasei Therapeutics Venture Capital | Series B |
| Forbion | Series B, Series A |
| Seroba Life Sciences | Series B |
| Forbion Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Will present at J.P. Morgan's 44th Annual Healthcare Conference.
- Jun 9, 2025
Will present at the BIO International Convention 2025.
Azafaros Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Azafaros's valuation, stock price, and market status.